UPDATE : Wednesday, June 19, 2019
상단여백
Samsung Bioepis’ biosimilar sales in EU exceed $500 million by Lee Han-soo 2019-01-30 18:17
KIST finds boiling histotripsy’s mechanism to remove tumor tissue by Cho In-sung 2019-01-24 11:30
FDA OKs Samsung Bioepis’ first oncology medicine by Lee Han-soo 2019-01-21 11:43
Celltrion wins patent dispute on Truxima by Lee Han-soo 2019-01-18 11:47
Over 1,000 bio-ventures set up in past 3 years by Lee Han-soo 2019-01-17 22:05
라인
CL Bio wins patent for substance that improves antidiabetic functions by Lee Han-soo 2019-01-14 12:34
Medipost, LG Chem to develop stem cell therapy by Lee Han-soo 2019-01-08 17:55
Samsung Bioepis to expand business in China by Lee Han-soo 2019-01-07 12:30
Celltrion’s Truxima claims 35% of European rituximab market by Lee Han-soo 2019-01-04 15:54
Alteogen wins patent on optimizing incubation conditions for Eylea biosimilar by Lee Han-soo 2019-01-03 16:01
라인
Newly listed pharmaceuticals suffer market cap declines by Nam Doo-hyun 2018-12-21 15:13
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy by Nam Doo-hyun 2018-12-17 12:48
Samsung BioLogics’ market cap rises after accounting issue by Nam Doo-hyun 2018-12-13 15:33
‘Bispecific antibody market offers promising outlook’ by Nam Doo-hyun 2018-12-12 16:27
Samsung BioLogics, Celltrion shares soar despite uncertainty by Lee Han-soo 2018-12-12 16:27
라인
Machine learning finds biomarker for rare Castleman Disease by Lee Hye-seon 2018-12-11 17:11
Viromed finds prostate hyperplasia treatment effect in natural substance by Lee Han-soo 2018-12-11 14:55
Samsung BioLogics resumes trading despite controversies by Lee Han-soo 2018-12-11 10:50
Celltrion unveils clinical trial results for rituximab biosimilar in US by Lee Han-soo 2018-12-06 11:11
Samsung BioLogics, Saint-Gobain sign supply agreement by Lee Han-soo 2018-12-05 14:01
여백
여백
여백
Back to Top